Article Text

Download PDFPDF

Homozygosity mapping of autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy (CMT4H) to a novel locus on chromosome 12p11.21-q13.11
  1. A De Sandre-Giovannoli1,*,
  2. V Delague2,*,
  3. T Hamadouche2,
  4. M Chaouch3,
  5. M Krahn2,
  6. I Boccaccio2,
  7. T Maisonobe4,
  8. E Chouery5,
  9. R Jabbour7,
  10. S Atweh7,
  11. D Grid6,
  12. A Mégarbané5,
  13. N Lévy1
  1. 1Inserm U491 and Département de Génétique Médicale, Campus Hospitalier et Universitaire de la Timone, Marseille, France
  2. 2Inserm U491, Génétique Médicale et Développement, Faculté de Médecine de la Timone, Marseille, France
  3. 3Service de Neurologie, Centre Hospitalier Universitaire Ben Aknoun, Algiers, Algeria
  4. 4Service de Neuropathologie, Hôpital de la Salpêtrière, Paris, France
  5. 5Unité de Génétique Médicale, Université Saint-Joseph, Faculté de Médecine, Beirut, Lebanon
  6. 6Généthon III, Evry, France
  7. 7American University of Beirut Medical Center, Beirut, Lebanon
  1. Correspondence to:
 Dr Nicolas Lévy
 INSERM U491, Génétique Médicale et Développement, Faculté de Médecine de la Timone, 13385 Marseille Cedex 05, France;

Statistics from

Hereditary motor and sensory neuropathies, commonly referred to as Charcot-Marie-Tooth disease (CMT), are among the most common inherited neurological diseases, with an overall prevalence of about 1–4/10 000.1 Clinically, the hereditary motor and sensory neuropathies are characterised by progressive muscular and sensory loss in the distal extremities with chronic distal weakness, deformation of the feet (pes cavus), and loss of deep tendon reflexes.2 Two main subgroups have been defined on the basis of electrophysiological and histopathological characteristics: the demyelinating form (CMT1) and the axonal form (CMT2). CMT1 can be distinguished from CMT2 by measuring motor nerve conduction velocities in the median nerve: patients affected by CMT1 show reduced velocities (<38 m/s), whereas those affected by CMT2 show velocities of ⩾38 m/s, the normal value being ⩾48 m/s. Recently, a new group of CMT has been described, referred to as intermediate CMT3,4; in this, nerve conduction velocities overlap CMT1 and CMT2, and nerve biopsies present characteristics of both demyelination and axonal loss.

CMT is also characterised by great genetic heterogeneity, with more than 30 loci and 19 genes identified to date5,6 (inherited peripheral neuropathy mutation database, IPNMDB, All modes of inheritance have been reported: autosomal dominant, autosomal recessive, and X linked. Autosomal recessive demyelinating forms (CMT4) are, in most cases, less frequent, of earlier onset, and more severe than the autosomal dominant CMT forms (CMT1), with a fast progression to severe disability leading to a higher frequency of wheelchair dependency early in life.7 To date, at least seven demyelinating forms with autosomal recessive inheritance have been identified:

  • CMT4A (MIM 214400) at chromosome 8q13–q21.18,9 caused by mutations in the ganglioside induced differentiation associated protein 1 gene (GDAP1, MIM 606598),10,11 together with mixed demyelinating and axonal autosomal recessive phenotypes …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.